Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy

por Guan, Shuxiao, Suman, Shankar, Amann, Joseph M., Wu, Ruohan, Carbone, David P., Wang, Jie, Dikov, Mikhail M.
Publicado 2022

LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT

por Kaufman, Jacob M., Amann, Joseph M., Park, Kyungho, Arasada, Rajeswara Rao, Li, Haotian, Shyr, Yu, Carbone, David P.
Publicado 2014

RANBP9 as potential therapeutic target in non-small cell lung cancer

por Tessari, Anna, Soliman, Shimaa H. A., Orlacchio, Arturo, Capece, Marina, Amann, Joseph M., Visone, Rosa, Carbone, David P., Palmieri, Dario, Coppola, Vincenzo
Publicado 2020

Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung

por Wang, Walter Z., Shilo, Konstantin, Amann, Joseph M., Shulman, Alyssa, Hojjat-Farsangi, Mohammad, Mellstedt, Håkan, Schultz, Johan, Croce, Carlo M., Carbone, David P.
Publicado 2021

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC

por Ikarashi, Daiki, Okimoto, Tamio, Shukuya, Takehito, Onagi, Hiroko, Hayashi, Takuo, Sinicropi-Yao, Sara L., Amann, Joseph M., Nakatsura, Tetsuya, Kitano, Shigehisa, Carbone, David P.
Publicado 2021